Assessing the Impact of Glucagon-like Peptide-1 and Glucagon-like Peptide-1/glucose-dependent Insulinotropic Polypeptide Receptor Agonist Shortages on Glycemic Control: A Single Center Study

Christian Dacon, Pramodini Kale-Pradhan, Melissa Lipari, Department of Pharmacy, Henry Ford St, John Hospital, Pharmacy practice, Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences

Journal of Pharmacy Practice

Published online on May 05, 2026

Abstract

Journal of Pharmacy Practice, Ahead of Print.
Background:Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual GLP-1/glucose-dependent insulinotropic polypeptide receptor agonists (GLP-1/GIP RAs) effectively manage type 2 diabetes mellitus (T2DM). Recent medication shortages have impacted ...